Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Guggenheim

S&P SmallCap 600 Pure Value Fund Class A (RYSVX)

Ticker RYSVX · · Holdings as of Jun 30, 2026

Expense ratio
1.53%$153/yr per $10k
5-yr return
+10.8%annualized
1-yr return
+1.6%as of Dec 2025
Net assets
$9.4Mall share classes
Holdings
158

Bottom line

Is RYSVX a good fund? The bottom line

RYSVX is the Class A share class of S&P SmallCap 600 Pure Value Fund, a managed small-cap mutual fund from Guggenheim.

Annual fees run 1.53% — about $153 a year on every $10,000 invested, more expensive than 87% of small-cap funds we track.

It returned +1.6% over one year, +10.8% a year over five years, +6.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $9.4 million in net assets and 158 holdings, its largest position is Ichor Holdings Ltd (3.6%) and the top 10 make up 20.6% of the portfolio.

This share class carries a front-end sales charge of up to 4.75%; a no-load class or ETF alternative can avoid it.

What stands out

  • 5-year return beat 89% of category peers

What to watch

  • Expensive for its category (1.53%)
  • Front-end sales load up to 4.75%
  • 12b-1 marketing fee of 0.25% a year
  • Small fund ($9.4 million) — small funds are likelier to close
  • High turnover (3,783% a year) can mean more taxable distributions

Updated Nov 19, 2026

What RYSVX invests in

The S&P SmallCap 600 Pure Value Fund (the Fund) seeks to provide investment results that match, before fees and expenses, the performance of a benchmark for small-cap value securities on a daily basis. The Funds current benchmark is the S&P SmallCap 600 Pure Value Index (the underlying index).

The Fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and derivative instruments, which primarily consist of equity index swaps, futures contracts, and options on securities, futures contracts, and stock indices. While the Fund may write (sell) and purchase swaps, it expects primarily to purchase swaps. Equity index swaps and futures and options contracts enable the Fund to pursue its investment objective without investing directly in the securities included in the underlying index or in the same proportion that those securities are represented in the underlying index. Certain of the Funds derivatives investments may be traded in the over-the-counter (OTC) market. Under normal circumstances, the Fund will invest at least 80% of its net assets, plus any borrowings for…

From the fund's prospectus (filed Jul 29, 2026).

RYSVX performance

Average annual total returns
1 yr5 yr10 yr
RYSVX+1.6%+10.8%+6.8%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full RYSVX performance history →

What RYSVX costs

On a $10,000 investment, RYSVX's 1.53% expense ratio costs about $153 a year. The prospectus estimates $2,260 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full RYSVX fee table →

RYSVX top 10 holdings

#Holding% of fund
1Ichor Holdings Ltd ICHR3.62%
2Acadia Healthcare Company Inc ACHC2.21%
3Newell Brands Inc NWL1.99%
4Vestis Corp VSTS1.95%
5Vishay Intertechnology Inc VSH1.94%
6Dreyfus Treasury Obligations Cash Management1.89%
7Edgewell Personal Care Company EPC1.82%
8Arcbest Corp ARCB1.75%
9Molina Healthcare Inc MOH1.73%
10Marinemax Inc HZO1.69%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to RYSVX

More funds like RYSVX →

RYSVX FAQ

What is the expense ratio of RYSVX?
RYSVX's expense ratio is 1.53%, which works out to about $153 a year for every $10,000 invested. The prospectus estimates total costs of $2,260 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RYSVX a good investment?
It depends on your goals, but the data points to: 5-year return beat 89% of category peers; expensive for its category (1.53%); front-end sales load up to 4.75%; 12b-1 marketing fee of 0.25% a year; small fund ($9.4 million) — small funds are likelier to close; high turnover (3,783% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does RYSVX hold?
RYSVX's largest holdings are Ichor Holdings Ltd (3.6%), Acadia Healthcare Company Inc (2.2%), Newell Brands Inc (2.0%), Vestis Corp (1.9%), Vishay Intertechnology Inc (1.9%). It holds 158 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is RYSVX's 5-year return?
RYSVX returned +10.8% a year over the five years ending Dec 31, 2025, and +6.8% a year over ten years. Past performance does not guarantee future results.
Does RYSVX have a sales load?
Yes. RYSVX has a maximum front-end sales charge of 4.75%.
Who manages RYSVX?
RYSVX is offered by Guggenheim through Rydex Series Funds.